Valsartan is a widely-used prescription drug used to treat high blood pressure. It is also known by its generic name, Diovan. As with any medication, it is important to understand and follow the proper dosage instructions in order to ensure that your health remains safe. But how much Valsartan is too much? In this blog post, we’ll discuss what the right dose of Valsartan is and why it’s important to pay attention to the amount you take. We’ll also cover potential side effects of taking too much and how you can avoid them. Read on for more!
Valsartan is an angiotensin II receptor antagonist (ATRA) used to treat high blood pressure, congestive heart failure, and to reduce the risk of strokes. It works by relaxing blood vessels so that blood can flow more easily. It is also used in some patients after a heart attack. Valsartan can be taken with or without food.
Common side effects of Valsartan may include dizziness, headache, nausea, and diarrhea.
The recommended doses of Valsartan vary depending on the condition being treated. For hypertension, the usual recommended starting dose is 80 mg once daily. The dosage may be increased to a maximum of 320 mg once daily if needed. For congestive heart failure, the starting dose is 40 mg twice daily, with the dosage gradually increased as needed up to a maximum of 160 mg twice daily.
1. Dizziness
2. Lightheadedness
3. Fatigue
4. Nausea
5. Diarrhea
6. Headache
7. Dry mouth
8. Increased urination
If you are prescribed Valsartan, it is important to take the correct dose. The amount of medicine that you need to take may be different for different people.
If you miss a dose of Valsartan, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses of Valsartan at the same time.
Taking too much valsartan dosage can be dangerous, so it is important to understand the correct dosage for your condition.
1.
Lesser-known lobular breast cancer on the rise in U.S. women
2.
Study finds that AI is better at forecasting the risk of developing cancer.
3.
Kate Middleton and Remission: Oncologists Weigh In
4.
According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.
5.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
1.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
2.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
3.
Tumor-Specific Fluorescent Peptide Navigation in Surgical Oncology
4.
Digital Blood Cell Morphology Libraries for Longitudinal Hematologic Monitoring
5.
The importance of understanding normal serum osmolality
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Best Practices in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation